Fig. 2
Body mass following doxorubicin injection (A) according to intervention groups, there is a significant time effect (p < 0.001); (B) according to exercise compliance, there is a significant (p = 0.018) time*compliance interaction and a significant time effect (p < 0.001). ***P < 0.001, represents repeated measures ANOVA Bonferroni corrected post hoc for time effect. Values are mean ± SD. C, compliant (n = 12); G1, HIIE day 1 post-DOX (n = 7); G2, HIIE day 2 post-DOX (n = 7); G3, HIIE day 3 post-DOX (n = 8); N-C, non-compliant (n = 10) and SED, no exercise (n = 6)